{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:30:49Z","timestamp":1768908649555,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02149","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T17:07:11Z","timestamp":1736442431000},"page":"e02149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ceftazidime-resistance in pediatric melioidosis: A case report and literature review"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-4941","authenticated-orcid":false,"given":"Tonnii Loong-Loong","family":"Sia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Dekun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamilah","family":"Manan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Lung","family":"Khiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Zakiyyah","family":"Bakhtiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yek-Kee","family":"Chor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Lin","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee-See","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mong-How","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.idcr.2025.e02149_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00006-19","article-title":"Human Melioidosis","volume":"33","author":"Gassiep","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02149_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment","volume":"36","author":"Currie","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02149_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/21.2.171","article-title":"Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminoglycoside antibiotics","volume":"21","author":"McEniry","year":"1988","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02149_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003495-198529020-00002","article-title":"Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"29","author":"Richards","year":"1985","journal-title":"Drugs"},{"issue":"8665","key":"10.1016\/j.idcr.2025.e02149_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(89)90768-X","article-title":"Halving of mortality of severe melioidosis by ceftazidime","volume":"2","author":"White","year":"1989","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02149_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008659","article-title":"2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift","volume":"14","author":"Sullivan","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idcr.2025.e02149_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijmmb.2022.09.006","article-title":"Ceftazidime-resistant Burkholderia pseudomallei masquerading as isolated atypical neuromelioidosis","volume":"41","author":"Agrawal","year":"2023","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.idcr.2025.e02149_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/121845","article-title":"The in vitro antibiotic susceptibility of Malaysian isolates of Burkholderia pseudomallei","volume":"2013","author":"Ahmad","year":"2013","journal-title":"Int J Microbiol"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02149_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1995-7645(12)60050-9","article-title":"Ceftazidime resistance in Burkholderia pseudomallei: first report from India","volume":"5","author":"Behera","year":"2012","journal-title":"Asian Pac J Trop Med"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02149_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/ijmm.IJMM_19_367","article-title":"Melioidosis in Odisha: a clinico-microbiological and epidemiological description of culture-confirmed cases over a 2-year period","volume":"37","author":"Behera","year":"2019","journal-title":"Indian J Med Microbiol"},{"issue":"41","key":"10.1016\/j.idcr.2025.e02149_bib11","doi-asserted-by":"crossref","first-page":"17165","DOI":"10.1073\/pnas.1111020108","article-title":"Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei","volume":"108","author":"Chantratita","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02149_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/24.3.295","article-title":"The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment","volume":"24","author":"Dance","year":"1989","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02149_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/28.2.321","article-title":"Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei","volume":"28","author":"Dance","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2025.e02149_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IDR.S154696","article-title":"Imported melioidosis in Japan: a review of cases","volume":"11","author":"Hadano","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02149_bib15","first-page":"680","article-title":"Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia","volume":"45","author":"Hassan","year":"2014","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02149_bib16","first-page":"478","article-title":"Epidemiological surveillance of melioidosis in Singapore","volume":"27","author":"Heng","year":"1998","journal-title":"Ann Acad Med Singap"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02149_bib17","article-title":"Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of beta-lactam-resistant isolates","volume":"95","author":"Fen","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idcr.2025.e02149_bib18","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.12669\/pjms.38.8.5506","article-title":"A clinical study on clinical features,manifestations and drug resistance of melioidosis","volume":"38","author":"Hui","year":"2022","journal-title":"Pak J Med Sci"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02149_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0924-8579(00)00334-4","article-title":"Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis","volume":"17","author":"Jenney","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02149_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0974-2727.154800","article-title":"Melioidosis as a cause of acute abdomen in immuno-competent male from eastern India","volume":"7","author":"Karuna","year":"2015","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.idcr.2025.e02149_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/132971","article-title":"Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients","volume":"2014","author":"Khosravi","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02149_bib22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.47102\/annals-acadmedsg.V39N12p945","article-title":"Development of ceftazidime resistance in Burkhoderia pseudomallei in a patient experiencing melioidosis with mediastinal lymphadenitis","volume":"39","author":"Kung","year":"2010","journal-title":"Ann Acad Med Singap"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02149_bib23","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3201\/eid1510.090246","article-title":"Melioidosis in a tropical city state, Singapore","volume":"15","author":"Lo","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02149_bib24","first-page":"S46","article-title":"Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility","volume":"92","author":"Paveenkittiporn","year":"2009","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02149_bib25","article-title":"Resistance pattern of Burkholderia pseudomallei from clinical isolates at Dr. Saiful Anwar general hospital, Malang-Indonesia","volume":"1","author":"Rahayu","year":"2014","journal-title":"J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02149_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014461","article-title":"Molecular epidemiology and antibiotic resistance of Burkholderia pseudomallei isolates from Hainan, China: a STROBE compliant observational study","volume":"98","author":"Rao","year":"2019","journal-title":"Med (Baltim)"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02149_bib27","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/JCM.01657-08","article-title":"Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei","volume":"47","author":"Sam","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02149_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030789","article-title":"Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia","volume":"7","author":"Sarovich","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.idcr.2025.e02149_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IDR.S35529","article-title":"Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection","volume":"5","author":"Sarovich","year":"2012","journal-title":"Infect Drug Resist"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02149_bib30","first-page":"DD01","article-title":"Septicaemic melioidosis: case report from a non-endemic area","volume":"8","author":"Sood","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02149_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.35.3.484","article-title":"Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics","volume":"35","author":"Sookpranee","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idcr.2025.e02149_bib32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/INF.0b013e318258873b","article-title":"Pediatric suppurative parotitis in Cambodia between 2007 and 2011","volume":"31","author":"Stoesser","year":"2012","journal-title":"Pedia Infect Dis J"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02149_bib33","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0035-9203(08)70024-5","article-title":"Melioidosis: antibiogram of cases in Singapore 1987-2007","volume":"102","author":"Tan","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02149_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jac\/dkh471","article-title":"Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents","volume":"54","author":"Thibault","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02149_bib35","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1128\/AAC.05517-11","article-title":"Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand","volume":"55","author":"Wuthiekanun","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02149_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab460","article-title":"Epidemiological and clinical characteristics of melioidosis caused by gentamicin-susceptible Burkholderia pseudomallei in Sarawak, Malaysia","volume":"8","author":"Sia","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.idcr.2025.e02149_bib37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/444456","article-title":"Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis","volume":"41","author":"Chierakul","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02149_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005650","article-title":"Pediatric melioidosis in Sarawak, Malaysia: epidemiological, clinical and microbiological characteristics","volume":"11","author":"Mohan","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02149_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","article-title":"Emergence and spread of antibiotic resistance following exposure to antibiotics","volume":"35","author":"Canton","year":"2011","journal-title":"FEMS Microbiol Rev"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02149_bib40","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/AAC.38.5.931","article-title":"Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model","volume":"38","author":"Mouton","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02149_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/AAC.40.1.61","article-title":"Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections","volume":"40","author":"Nicolau","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02149_bib42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","article-title":"Augmented renal clearance in critically Ill patients: a systematic review","volume":"57","author":"Bilbao-Meseguer","year":"2018","journal-title":"Clin Pharm"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02149_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02149_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02149_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-0043-1770067","article-title":"In vitro susceptibility of Burkholderia pseudomallei isolates to cefiderocol and ceftazidime\/avibactam from Odisha, India","volume":"15","author":"Jena","year":"2023","journal-title":"J Lab Physicians"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T05:56:48Z","timestamp":1744523808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":45,"alternative-id":["S2214250925000046"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02149","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftazidime-resistance in pediatric melioidosis: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02149"}}